Based on the VanEck Genomics and Healthcare Innovators UCITS ETF GBP stock forecast from 0 analysts, the average analyst target price for VanEck Genomics and Healthcare Innovators UCITS ETF GBP is not available over the next 12 months. VanEck Genomics and Healthcare Innovators UCITS ETF GBP’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of VanEck Genomics and Healthcare Innovators UCITS ETF GBP is Very Bearish, which is based on 0 positive signals and 1 negative signals. At the last closing, VanEck Genomics and Healthcare Innovators UCITS ETF GBP’s stock price was GBP 14.95. VanEck Genomics and Healthcare Innovators UCITS ETF GBP’s stock price has changed by -3.12% over the past week, -1.86% over the past month and 0% over the last year.
Analyst Ratings
Target Price Action
Rating Action
Analyst
Rating
Price
Date
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Add to Watchlists
loading..
Download Confirmation
Premium customers can only download records visible on the current page view, while Platinum customers can download the first 1000 records.
Paid-only feature
CSV downloads are only available for paying customers.
Thank you for Sharing your Stock Targets for CURG:LSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
